| Title |
Should we reconsider the routine use of placebo controls in clinical research?
|
|---|---|
| Published in |
Trials, April 2012
|
| DOI | 10.1186/1745-6215-13-44 |
| Pubmed ID | |
| Authors |
Andrew L Avins, Daniel C Cherkin, Karen J Sherman, Harley Goldberg, Alice Pressman |
| Abstract |
Modern clinical-research practice favors placebo controls over usual-care controls whenever a credible placebo exists. An unrecognized consequence of this preference is that clinicians are more limited in their ability to provide the benefits of the non-specific healing effects of placebos in clinical practice. |
X Demographics
The data shown below were collected from the profiles of 4 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Australia | 1 | 25% |
| Colombia | 1 | 25% |
| Unknown | 2 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 3 | 75% |
| Scientists | 1 | 25% |
Mendeley readers
The data shown below were compiled from readership statistics for 72 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 1 | 1% |
| Unknown | 71 | 99% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 13 | 18% |
| Student > Bachelor | 13 | 18% |
| Researcher | 6 | 8% |
| Other | 5 | 7% |
| Professor | 5 | 7% |
| Other | 15 | 21% |
| Unknown | 15 | 21% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 39% |
| Nursing and Health Professions | 7 | 10% |
| Agricultural and Biological Sciences | 5 | 7% |
| Psychology | 4 | 6% |
| Pharmacology, Toxicology and Pharmaceutical Science | 2 | 3% |
| Other | 8 | 11% |
| Unknown | 18 | 25% |